Teligent Overview

  • Founded

  • 1977

Founded
  • Status

  • Public

  • Employees

  • 142

Employees
  • Investments

  • 8

  • Share Price

  • $0.02

  • (As of Friday Closing)

Teligent General Information

Description

Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.

Contact Information

Website
www.teligent.com
Formerly Known As
IGI Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Former Stock Listing
0IGA
Primary Office
  • 105 Lincoln Avenue
  • Buena, NJ 08310
  • United States
+1 (856) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teligent Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.02 - $0.65 $186K 92.8M 1.08K -$7.57

Teligent Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 152,170 205,913
Revenue 46,297 45,309 65,896 65,865
EBITDA (62,330) (84,711) 2,817 (18,345)
Net Income (91,567) (122,022) (25,124) (36,256)
Total Assets 90,419 87,788 206,905 190,892
Total Debt 116,981 162,644 186,815 153,982
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Teligent Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Teligent‘s full profile, request access.

Request a free trial

Teligent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own la
Medical Supplies
Buena, NJ
142 As of 2020
000.00
0000000000.

000000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
000000000000000
South Brunswick Township, NJ

00000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labor
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Teligent Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guardian Drug Company Corporation South Brunswick Township, NJ
00000 000000000000 Corporation Ahmedabad, India 00000 000.00 00000000 000.00
0000000 0000000 Corporation Dublin, Ireland 0000 000000&0
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 00000000000 00000
000000 Corporation North Chicago, IL 000000 0000
You’re viewing 5 of 17 competitors. Get the full list »

Teligent Patents

  • 1

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Teligent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-1196800-A An integrated system for the management of network user message information across various communication systems Inactive 30-Sep-1998 000000000

Teligent Executive Team (16)

Name Title Board Seat Contact Info
Alyssa Lozynski Chief Financial Officer, Finance
Keith James Chief Accounting Officer, Accounting
Philip Yachmetz JD Chief Legal Officer & Corporate Secretary
You’re viewing 3 of 16 executive team members. Get the full list »

Teligent Board Members (10)

Name Representing Role Since
00000000 000000 Teligent Board Member 000 0000
000000 0000000 Teligent Board Member 000 0000
You’re viewing 2 of 10 board members. Get the full list »

Teligent Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teligent Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 13-Nov-2015 0000000000 000.00 Pharmaceuticals 00000 000
000000000 000 01-Oct-2015 0000000000 000.00 Pharmaceuticals 00000 000
0000000 00000 01-Oct-2014 0000000000 00.00 Drug Discovery 00000 000
00000000000 ( 25-Sep-2014 0000000000 00.00 Drug Delivery 00000 000
Prasco (Econazole Nitrate Cream) 02-Feb-2013 Corporate Asset Purchase 00.00 Buildings and Property 00000 000
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Teligent ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Teligent’s complete esg history, request access »

Teligent Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 04-Oct-2000 000000000000000000 0000 Completed
  • 00000000
To view Teligent’s complete exits history, request access »